SHELBIE ZAMARRON: Open Payments
NPI 1982398731 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 17 payments from 10 companies in 2025. Trend: 2023 $21 · 2024 $1,063 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 4 | $204 |
| Biogen, Inc. | 5 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $91 |
| Dexcom, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Ethicon US, LLC | 1 | $16 |
| Hologic Sales and Service, LLC | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
Products named: TWIRLA, ZURZUVAE, XIFAXAN, Dexcom G6 Transmitter, SLYND, LILETTA, Exparel, VISTASEAL.
Industry payments across TX — which companies pay providers there.
